参考文献/References:
[1] Weigert J, Neumeier M, Wanninger J, et al. Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes[J].Clin Endocrinol(Oxf), 2010,72(3):342-348.
[2] Roman AA, Parlee SD, Sinal CJ. Chemerin: a potential endocrine Link between obesity and type 2 diabetes[J].Endocrine, 2012,42(2):243-251.
[3] Bozaoglu K, Curran JE, Stocker CJ, et al. Chemerin, a novel adipokine in the regulation of angiogenesis[J].J Clin Endocrinol Metab, 2010,95(5):2476-2485.
[4] Takahashi M, Inomata S, Okimura Y, et al. Decreased serum chemerin levels in male Japanese patients with type 2 diabetes: sex dimorphism[J].Endocr J, 2013,60(1):37-44.
[5] Chamberland JP, Berman RL, Aronis KN, et al. Chemerin is expressed mainly in pancreas and liver, is regulated by energy deprivation, and lacks day/night variation in humans[J].Eur J Endocrinol, 2013,169(4):453-462.
[6] Parlee SD, Ernst MC, Muruganandan S, et al. Serum chemerin levels vary with time of day and are modified by obesity and tumor necrosis factor-{alpha}[J].Endocrinology, 2010,151(6):2590-2602.
[7] Wittamer V, Franssen JD, Vulcano M, et al. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids[J].J Exp Med, 2003,198(7):977-985.
[8] Rourke JL, Muruganandan S, Dranse HJ, et al. Gpr1 is an active chemerin receptor influencing glucose homeostasis in obese mice[J].J Endocrinol, 2014,222(2):201-215.
[9] Mattern A,Zellmann T, Beck-Sickinger AG.Processing, signaling, and physiological function of chemerin[J].IUBMB Life, 2014,66(1):19-26.
[10] Spiroglou SG, Kostopoulos CG, Varakis JN, et al. Adipokines in periaortic and epicardial adipose tissue: differential expression and relation to atherosclerosis[J].J Atheroscler Thromb, 2010,17(2):115-130.
[11] Ernst MC, Sinal CJ. Chemerin: at the crossroads of inflammation and obesity[J].Trends Endocrinol Metab, 2010,21(11):660-667.
[12] Kukla M, Zwirska-Korczala K, Gabriel A, et al. Chemerin, vaspin and insulin resistance in chronic hepatitis C[J].J Viral Hepat, 2010,17(9):661-667.
[13] Nakajima H, Nakajima K, Nagano Y, et al. Circulating level of chemerin is upregulated in psoriasis[J].J Dermatol Sci, 2010,60(1):45-47.
[14] Cash JL, Hart R, Russ A, et al. Synthetic chemerin-derived peptides suppress inflammation through ChemR23[J].J Exp Med, 2008,205(4):767-775.
[15] Yoshimura T, Oppenheim JJ. Chemerin reveals its chimeric Nature[J].J Exp Med, 2008,205(10):2187-2190.
[16] Tönjes A, Fasshauer M, Kratzsch J, et al. Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes[J].PLoS One, 2010,5(11):e13911.
[17] Osman MM, Abd El-Mageed AI, El-hadidi EA, et al. Clinical utility of serum chemerin as a novel marker of metabolic syndrome and type 2 diabetes mellitus[J].Life Sci J, 2012,9(2):1098-1108.
[18] Ernst MC, Issa M, Goralski KB, et al. Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes[J].Endocrinology, 2010,151(5):1998-2007.
[19] Takahashi M, OkimuraY, Iguchi G, et al. Chemerin regulates b-cell function in mice[J].Sci Rep,2011,1:123.
[20] Takahashi M, Takahashi Y, Takahashi K, et al. Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes[J].FEBS Lett, 2008,582(5):573-578.
[21] Kralisch S, Weise S, Sommer G, et al. Interleukin-1beta induces the novel adipokine chemerin in adipocytes in vitro[J].Regul Pept, 2009,154(1-3):102-106.
[22] Sell H, Laurencikiene J, Taube A, et al. Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells[J].Diabetes, 2009,58(12):2731-2740.
[23] Jialal I, Devaraj S, Kaur H, et al. Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome[J].J Clin Endocrinol Metab, 2013,98(3):E514-E517.
[24] Bozaoglu K, Segal D, Shields KA, et al. Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population[J].J Clin Endocrinol Metab,2009,94(8):3085-3088.
[25] Chakaroun R, Raschpichler M, Klöting N, et al. Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity[J].Metabolism, 2012,61(5):706-714.
[26] Stejskal D, Karpisek M, Hanulova Z, et al. Chemerin is an independent marker of the metabolic syndrome in a Caucasian population--a pilot study[J].Biomed pap Med Facu Univ Palacky Olomouc Czech Repub, 2008,152(2):217-221.
[27] Schultz S, Beck-Sickinger AG. Chemerin and vaspin: possible targets to treat obesity[J].ChemMedChem, 2013,8(4):549-559.
[28] Doyle JR, Krishnaji ST, Zhu G, et al. Development of a membrane-anchored chemerin receptor agonist as a novel modulator of allergic airway inflammation and neuropathic pain[J].J Biol Chem, 2014,289(19):13385-13396.
相似文献/References:
[1]李雅,王志斌,刘玮晔,等.巨噬细胞与糖尿病肾病[J].国际内分泌代谢杂志,2014,(06):393.[doi:10.3760/cma.j.issn.1673-4157.2014.06.009]
Li Ya*,Wang Zhibin,Liu Weiye,et al.Macrophages and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2014,(05):393.[doi:10.3760/cma.j.issn.1673-4157.2014.06.009]
[2]翟丽敏,叶山东.二甲双胍的抗炎作用及其糖尿病肾脏保护作用[J].国际内分泌代谢杂志,2014,(05):334.[doi:10.3760/cma.j.issn.1673-4157.2014.05.013]
Zhai Limin,Ye Shandong..Anti-inflammatory effects of metformin and its renal protection in diabetes[J].International Journal of Endocrinology and Metabolism,2014,(05):334.[doi:10.3760/cma.j.issn.1673-4157.2014.05.013]
[3]聂秀玲,李明珍,孙丽荣.高尿酸血症与非酒精性脂肪性肝病[J].国际内分泌代谢杂志,2016,36(02):89.[doi:10.3760/cma.j.issn.1673-4157.2016.02.004]
Nie Xiuling,Li Mingzhen,Sun Lirong..Hyperuricemia and non-alcoholic fatty liver[J].International Journal of Endocrinology and Metabolism,2016,36(05):89.[doi:10.3760/cma.j.issn.1673-4157.2016.02.004]
[4]徐传翀,尚文斌.脂肪固有免疫细胞与胰岛素抵抗[J].国际内分泌代谢杂志,2016,36(04):257.[doi:10.3760/cma.j.issn.1673-4157.2016.04.11]
Xu Chuanchong,Shang Wenbin.Innate immune cells in adipose tissue and insulin resistance[J].International Journal of Endocrinology and Metabolism,2016,36(05):257.[doi:10.3760/cma.j.issn.1673-4157.2016.04.11]
[5]林晓璐,张红,夏小慧,等.Exendin-4对高糖培养肾小球系膜细胞
ECM分泌的影响及相关机制[J].国际内分泌代谢杂志,2016,36(05):302.[doi:10.3760/cma.j.issn.1673-4157.2016.05.05]
Lin Xiaolu*,Zhang Hong,Xia Xiaohui,et al.Effects and mechanism of exendin-4 on extracellular matrix secretion of mesangial cells cultured in high glucose[J].International Journal of Endocrinology and Metabolism,2016,36(05):302.[doi:10.3760/cma.j.issn.1673-4157.2016.05.05]
[6]张群慧,陈明卫.miRNA与肥胖[J].国际内分泌代谢杂志,2017,37(01):35.[doi:10.3760/cma.j.issn.1673-4157.2017.01.10]
Zhang Qunhui,Chen Mingwei..microRNA and obesity[J].International Journal of Endocrinology and Metabolism,2017,37(05):35.[doi:10.3760/cma.j.issn.1673-4157.2017.01.10]
[7]郑仁东,茅晓东,张会峰,等.IL-6联合sIL-6R对人甲状腺细胞增殖
及相关基因表达的影响[J].国际内分泌代谢杂志,2017,37(02):82.[doi:10.3760/cma.j.issn.1673-4157.2017.02.003]
Zheng Rendong,Mao Xiaodong,Zhang Huifeng,et al.Effects of IL-6 plus sIL-6R on cell proliferation and expression of related genes in human thyroid cells[J].International Journal of Endocrinology and Metabolism,2017,37(05):82.[doi:10.3760/cma.j.issn.1673-4157.2017.02.003]
[8]龚凡,陆灏.IKKε调节代谢平衡及其机制[J].国际内分泌代谢杂志,2017,37(02):120.[doi:10.3760/cma.j.issn.1673-4157.2017.02.013]
Gong Fan,Lu Hao..IKKε regulate energy balance and its mechanism[J].International Journal of Endocrinology and Metabolism,2017,37(05):120.[doi:10.3760/cma.j.issn.1673-4157.2017.02.013]
[9]梁绮君,胡晨鸣,黄容,等.山楂消脂胶囊对肥胖症患者炎性状态
及脂多糖水平的影响[J].国际内分泌代谢杂志,2017,37(04):236.
Liang Qijun,Hu Chenming,Huang Rong,et al.Effects of Shanzha xiaozhi capsule on inflammation and lipopolysaccharide level in obese patients[J].International Journal of Endocrinology and Metabolism,2017,37(05):236.
[10]杨可来尔 匡洪宇.NLRP3炎性小体与糖尿病肾病[J].国际内分泌代谢杂志,2018,38(04):271.[doi:10.3760/cma.j.issn.1673-4157.2018.04.013]
Yang Kelai'er,Kuang Hongyu..NLRP3 inflammasome and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2018,38(05):271.[doi:10.3760/cma.j.issn.1673-4157.2018.04.013]